Apple is developing an innovative interface for controlling devices using the power of thought. The company is collaborating with the US startup Syncron, the creator of the Stentrode neuroimplant, to implement this project.One of the program participants is already using the Apple Vision Pro for communication and entertainment, activating the device's functions with the power of thought.

EDnews reports this with reference to The Wall Street Journal.

The unique feature of the Syncron implant is its minimal invasiveness. It is inserted through a jugular vein without the need for surgical intervention in the skull. The device reads neural signals associated with movement intention and translates them into commands for the iPhone, Apple Vision Pro, and other devices in the Apple ecosystem.

The technology is currently being tested among patients with movement disorders.Although this development is initially aimed at people with disabilities, it could become part of Apple’s core products in the future. The first versions of the technology will be compatible with third-party neuroimplants, and in the future the company plans to develop its own solutions.

Syncron emphasizes its advantage over competitors in the field such as Neuralink, noting a significantly less traumatic installation procedure that does not require a craniotomy. The technology is currently undergoing clinical trials and is awaiting approval from the US Food and Drug Administration.

Madina Mammadova\\EDnews